Article Detail - JF Part B
Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing - R3
This coverage article has been revised and published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).
Effective Date: July 31, 2020
Summary of Article Changes:
Addition of coding to Group 1:
C54.1 - Malignant neoplasm of endometrium
Z15.04 - Genetic susceptibility to malignant neoplasm of endometrium
Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.
Last Updated Thu, 09 Jul 2020 17:33:35 +0000